Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Hu‑Yong Zheng"'
Autor:
Shu-Guang Liu, Zhi-Xia Yue, Zhi-Gang Li, Rui-Dong Zhang, Hu-Yong Zheng, Xiao-Xi Zhao, Chao Gao
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Aberrant activation of β-catenin has been shown to play important roles in the chemoresistance of acute lymphoblastic leukemia (ALL), but the involvement and mechanism of β-catenin in methotrexate (MTX) resistance is poorly unde
Externí odkaz:
https://doaj.org/article/bea8e352849741409babcfac95d0c8c1
Autor:
Chao Gao, Shu-Guang Liu, Zhi-Xia Yue, Yi Liu, Jing Liang, Jun Li, Yuan-Yuan Zhang, Jiao-Le Yu, Ying Wu, Wei Lin, Hu-Yong Zheng, Rui-Dong Zhang
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Although leukemic blast cells of Pro-B cell acute lymphoblastic leukemia (ALL) are arrested at the same stage of B cell differentiation, the immature B cell subtype is still biologically heterogeneous and is associated with divers
Externí odkaz:
https://doaj.org/article/dfe286128000483184d5ddb6c89410ac
Autor:
Zhi-Xia Yue, Rui-qi Gao, Chao Gao, Shu-Guang Liu, Xiao-Xi Zhao, Tian-Yu Xing, Jing Niu, Zhi-Gang Li, Hu-Yong Zheng, Wei Ding
Publikováno v:
Cancer Cell International, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Cajal body (CB) is a nucleic organelle where small nuclear ribonucleoproteins undergo modification, maturation, splicing and/or assembly. Coilin is the marker structural protein of CBs. The expression level and cellular localizati
Externí odkaz:
https://doaj.org/article/7cf287fb57e94c898e37fbb48f169d27
Autor:
Meng-Ge Yu, Hu-Yong Zheng
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 2, Pp 211-218 (2017)
Objective: Leukemia is the most common pediatric malignancy and a major cause of morbidity and mortality in children. Among all subtypes, a lack of consensus exists regarding the diagnosis and treatment of acute myeloid leukemia (AML). Patient surviv
Externí odkaz:
https://doaj.org/article/ad3d3ca28a714ebfa0708e63fe9fd4f4
Autor:
Si-Dan Li, Yong-Bing Chen, Zhi-Gang Li, Run-Hui Wu, Mao-Quan Qin, Xuan Zhou, Jin Jiang, Rui-Dong Zhang, Jing Xie, Xiao-Li Ma, Rui Zhang, Bin Wang, Ying Wu, Hu-Yong Zheng, Min-Yuan Wu
Publikováno v:
Chinese Medical Journal, Vol 128, Iss 4, Pp 472-476 (2015)
Background: Infections remain a major cause of therapy-associated morbidity and mortality in children with acute lymphoblastic leukemia (ALL). Methods: We retrospectively analyzed the medical charts of 256 children treated for ALL under the CCLG-200
Externí odkaz:
https://doaj.org/article/1712959697994368b7c0e0d5ef09b1a2
Autor:
Hu-Yong Zheng
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 15, Pp 1765-1766 (2018)
Externí odkaz:
https://doaj.org/article/fb80f242060d49e7808624ab8a2e048b
Autor:
Fei-Fei Yang, Tian-Lin Xue, Chao Gao, Ying Wu, Wei Lin, Jun Li, Rui-Dong Zhang, Hu-Yong Zheng, Shu-Guang Liu
Publikováno v:
Pharmacogenomics. 23:821-834
Aim: To evaluate the association between SLCO1B1 polymorphisms and elimination/toxicities of high-dose methotrexate (MTX). Methods: SLCO1B1 rs11045879 and rs4149056 polymorphisms were retrospectively genotyped in 301 children with newly diagnosed acu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a176b604be1c830dc42fd64cc63ecf3a
https://doi.org/10.2217/pgs-2022-0098
https://doi.org/10.2217/pgs-2022-0098
Autor:
Yuan Yuan, Jun Li, Tian-Lin Xue, Hai-Rui Hu, Wei Lin, Shu-Guang Liu, Rui-Dong Zhang, Hu-Yong Zheng, Chao Gao
Publikováno v:
Leukemia & Lymphoma. 63:1624-1633
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13d533284e27621a174f90167ea41c55
https://doi.org/10.1080/10428194.2022.2032033
https://doi.org/10.1080/10428194.2022.2032033
Autor:
Fei-Fei, Yang, Tian-Lin, Xue, Chao, Gao, Ying, Wu, Wei, Lin, Jun, Li, Rui-Dong, Zhang, Hu-Yong, Zheng, Shu-Guang, Liu
Publikováno v:
Pharmacogenomics. 23(15)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f43c9620e31342383e6b13654fc16a8
https://pubmed.ncbi.nlm.nih.gov/36193736
https://pubmed.ncbi.nlm.nih.gov/36193736
Autor:
Zhigang Li, Xiao‑Xi Zhao, Zhen‑Ping Chen, Shu-Guang Liu, Tian‑Yu Xing, Zhi‑Xia Yue, Wen‑Ting Lu, Hu‑Yong Zheng, Chao Gao
Publikováno v:
Molecular Medicine Reports
Low expression levels of CREB‑binding protein (CREBBP) have been demonstrated to be associated with high minimal residual disease at the end of induction therapy and adverse long‑term outcomes in pediatric patients with acute lymphoblastic leukem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4545f524e63826837e7ccb7290de6451
http://europepmc.org/articles/PMC7453649
http://europepmc.org/articles/PMC7453649